ProLynx announces SBIR grant award to develop long-acting parathyroid hormone for hypo-parathyroidism SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) -- Today ProLynx announced it was awarded a Small Business Innovation Research (SBIR) grant from the NIH. The grant was conferred for the development of...